Degradation of selected pharmaceutical and personal care products (PPCPs) by white-rot fungi

Today, more than 3,000 pharmaceutical and personal care products (PPCPs) are used and released into the environment at low doses but they are barely degraded in wastewater treatment plants. One of the potential alternatives to effectively degrade PPCPs is based on the use of white-rot fungi (WRF) and involves the oxidative action of extracellular fungal enzymes. The aim of this work is to study the potential ability of three WRF strains, an anamorph species of Bjerkandera sp. R1, Bjerkandera adusta and Phanerochaete chrysosporium, to degrade PPCPs belonging to different therapeutic groups: anti-depressants (citalopram and fluoxetine), antibiotics (sulfamethoxazole), anti-inflammatory drugs (diclofenac, ibuprofen and naproxen), anti-epileptics (carbamazepine), tranquilizers (diazepam) and fragrances (celestolide, galaxolide and tonalide). The results reported complete degradation of all the PPCPs except for fluoxetine and diazepam, which were partially removed in percentages from 23 to 57%. In the case of fragrances, these compounds were neither detected in the fungal cultures nor in the abiotic controls, indicating the possibility of volatilization during the experiment.